Alzheimer's disease drug discovery

Alzheimer’s disease is the most common cause of age-related dementia. Alzheimer’s disease presents with irreversible cognitive decline, which commences as insidious short-term memory dysfunction and gradually spreads to other cognitive domains, rendering patients mute and non-ambulatory after 10-15...

Ausführliche Beschreibung

Bibliographische Detailangaben

Weitere Verfasser:	Huang, Xudong (HerausgeberIn)
Format:	Elektronisch E-Book
Sprache:	English
Veröffentlicht:	Brisbane, Australia Exon Publications December 2020
Schlagworte:	Arzneimittel Alzheimerkrankheit Etiology of Alzheimer’s Disease; Epidemiology of Alzheimer’s Disease; Neuropathology of Alzheimer’s Disease; Pathogenesis of Alzheimer’s Disease; Immunotherapy for Alzheimer’s Disease; Amyloid β-Targeted Inhibitory Peptides for Alzheimer’s Disease; Tau Protein-Targeted Therapies in Alzheimer’s Disease; Targeting Metal Homeostasis for Alzheimer’s Disease; Insulin-Resistant in Alzheimer’s Disease; Blood–Brain Barrier in Alzheimer’s Disease; Epigenetic Modifications in Alzheimer’s Disease; Chimeric Conjugates for Alzheimer’s Disease; Multifunctional Ligand Approach for Alzheimer’s Disease; Natural Products for Alzheimer’s Disease Aufsatzsammlung
Online-Zugang:	kostenfrei kostenfrei
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!